Medicine
NovoSeven RT kit
NovoSeven RT kit is a prescription medicine containing Coagulation factor viia, marketed by Novo Nordisk, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store protected from light. After reconstitution, store NOVOSEVEN RT either at…
Key facts
- Active ingredient (INN)
- Coagulation factor viia
- Brand
- NovoSeven RT
- Dosage form
- Kit
- Packs
- 1 kit and 5 more
- Marketing authorisation holder
- Novo Nordisk
- Manufacturer
- Novo Nordisk
- Origin register
- US FDA, United States
- Storage
- Store protected from light. After reconstitution, store NOVOSEVEN RT either at room temperature or refrigerated for up to 3 hours. Do not freeze reconstituted NOVOSEVEN RT or store in syringes.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3002.12Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 April 2008
- Identifiers
- RxCUI 798102, 798104DailyMed set ID ea65c32f-8518-4383-b621-17056c0eebc0NDC 0169-7010, 0169-7050, 0169-7205 +5Application BLA103665
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 kit in 1 kit * 1 mL in 1 vial, glass * 1 mL in 1 vial, glass | 0169-7010-01 | Novo Nordisk | 30 April 2008 |
| 1 kit in 1 kit * 2 mL in 1 vial, glass * 2 mL in 1 vial, glass | 0169-7020-01 | Novo Nordisk | 30 April 2008 |
| 1 kit in 1 kit * 8 mL in 1 vial, glass * 8 mL in 1 vial, glass | 0169-7040-01 | Novo Nordisk | 6 August 2010 |
| 1 kit in 1 kit * 5 mL in 1 vial, glass * 5 mL in 1 vial, glass | 0169-7050-01 | Novo Nordisk | 30 April 2008 |
| 1 kit in 1 kit * 1 mL in 1 vial, glass * 1 mL in 1 syringe, glass | 0169-7201-01 | Novo Nordisk | 29 October 2012 |
| 1 kit in 1 kit * 2 mL in 1 vial, glass * 2 mL in 1 syringe, glass | 0169-7202-01 | Novo Nordisk | 29 October 2012 |
| 1 kit in 1 kit * 5 mL in 1 vial, glass * 5 mL in 1 syringe, glass | 0169-7205-01 | Novo Nordisk | 29 October 2012 |
| 1 kit in 1 kit * 8 mL in 1 syringe, glass * 8 mL in 1 vial, glass | 0169-7208-01 | Novo Nordisk | 29 October 2012 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Coagulation factor viia is a prescription medicine indicated for treatment of bleeding episodes and peri-operative management in adults, among other approved uses. MedsAcross supplies Coagulation factor viia for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Coagulation factor viiaFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- NovoSeven RT prescribing information (Novo Nordisk) · U.S. National Library of Medicine, DailyMed
Need NovoSeven RT kit for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.